[Efficacy of visual rehabilitation of patients with pellucid marginal degeneration fitted with SPOT® scleral contact lenses]
| Autor: | C. Lambert, C. Benoist D’azy, Frédéric Chiambaretta, S. Bézé |
|---|---|
| Přispěvatelé: | Service d'Ophtalmologie [CHU Clermont-Ferrand], CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand, Direction de la recherche clinique et de l’innovation [CHU Clermont-Ferrand] (DRCI), CHU Clermont-Ferrand |
| Jazyk: | francouzština |
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male medicine.medical_specialty Visual acuity genetic structures Contact Lenses [SDV]Life Sciences [q-bio] Visual rehabilitation Pellucid marginal degeneration Visual Acuity Vision Low Corneal Diseases Cohort Studies Cornea 03 medical and health sciences 0302 clinical medicine Scleral lens Ophthalmology Prosthesis Fitting medicine Humans In patient Fluorescein Angiography Aged Retrospective Studies business.industry Corneal Topography Middle Aged medicine.disease University hospital eye diseases 3. Good health medicine.anatomical_structure Treatment Outcome Tolerability 030221 ophthalmology & optometry Female sense organs France medicine.symptom business Sclera Dilatation Pathologic |
| Zdroj: | Journal Français D'Ophtalmologie Journal Français D'Ophtalmologie, Elsevier Masson, 2020, 43, pp.e1-e5. ⟨10.1016/j.jfo.2019.11.004⟩ |
| ISSN: | 1773-0597 0181-5512 |
| DOI: | 10.1016/j.jfo.2019.11.004⟩ |
| Popis: | To assess visual improvement in patients with pellucid marginal degeneration (PMD) after fitting with SPOT® scleral contact lenses (Scleral ProtectionOcular Treatment, Laboratoires d'Appareillage Oculaire, Amphion-Les-Bains, France).We report a case series of 5 patients with PMD and unsatisfactory refractive correction managed at Clermont-Ferrand university hospital from January to December 2018 fitted with customized SPOT scleral lenses. We assessed the best-corrected visual acuity (BCVA) before and after fitting with SPOT, keratometric data and tolerability of the scleral lenses.Nine eyes of 5 patients aged 51.8±8.47 years were fitted. The BCVA was significantly improved from 0.51 logMAR (±0.39) to 0.04 logMAR (±0.07) (P0.001). Sixty-six percent of the patients recovered optimal BCVA. No serious adverse event was reported. The presence of whitish deposits and an inordinate amount of manipulation required were the main disadvantages of the lenses. Nevertheless, all the patients considered them to be comfortable.Fitting PMD patients who have failed conventional optical devices with SPOT scleral lenses significantly improves BCVA, without serious adverse events, allowing surgery to be deferred even when it appears to be unavoidable. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|